96 related articles for article (PubMed ID: 16381638)
1. [Effects of metformin on fatty liver in insulin-resistant rats].
Chen SQ; Liu Q; Sun H; Tang L; Deng JC
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):915-8. PubMed ID: 16381638
[TBL] [Abstract][Full Text] [Related]
2. [Establishing a rat insulin-resistant fatty liver model].
Chen SQ; Liu Q; Sun H; Zhang GL; Shi XF
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):105-8. PubMed ID: 15727695
[TBL] [Abstract][Full Text] [Related]
3. [Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding].
Gao ZQ; Lu FE; Dong H; Xu LJ; Wang KF; Zhou X
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):101-4. PubMed ID: 15727694
[TBL] [Abstract][Full Text] [Related]
4. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
5. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
6. [The expression of insulin signal transduction molecules and islet alpha cell insulin resistance].
Du RQ; Li HL; Yang WY; Xiao JZ; Lou DJ; Wang B; Bai XP; Pan L
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2542-6. PubMed ID: 17198562
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis].
Zhang H; Feng Q; Li HS; Chen SD; Wang XN; Peng JH; Zhang N; Hu YY
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):928-33. PubMed ID: 18782536
[TBL] [Abstract][Full Text] [Related]
8. Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin HZ; Yang SQ; Chuckaree C; Kuhajda F; Ronnet G; Diehl AM
Nat Med; 2000 Sep; 6(9):998-1003. PubMed ID: 10973319
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between NF-kappa B binding activity and expression of PPAR gamma-mRNA in the livers of rats with fatty liver disease].
Zhao CY; Wang JB; Deng ZJ; Liu JW; Li JM; Li L; Jiang LL
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):96-100. PubMed ID: 15727693
[TBL] [Abstract][Full Text] [Related]
10. [Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1 in liver and skeletal muscle and its influence on insulin sensitivity].
Bai XP; Li HL; Yang WY; Xiao JZ; Wang B; Du RQ; Lou DJ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):268-70. PubMed ID: 18361841
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid can significantly prevent early insulin resistance induced by a high-fat diet.
Wu M; Wang X; Duan Q; Lu T
Ann Nutr Metab; 2007; 51(3):270-6. PubMed ID: 17622786
[TBL] [Abstract][Full Text] [Related]
13. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat.
Raso GM; Esposito E; Iacono A; Pacilio M; Cuzzocrea S; Canani RB; Calignano A; Meli R
Eur J Pharmacol; 2009 Feb; 604(1-3):125-31. PubMed ID: 19135440
[TBL] [Abstract][Full Text] [Related]
14. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term high-saturated and unsaturated fatty acid diets on relaxation and contraction of renal arteries in insulin resistant rats.
Gao Y; Song GY; Ma HJ; Zhang WJ; Zhou Y
Sheng Li Xue Bao; 2007 Jun; 59(3):363-8. PubMed ID: 17579794
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
[TBL] [Abstract][Full Text] [Related]
17. Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver.
Tessari P; Tiengo A
Acta Diabetol; 2008 Sep; 45(3):143-5. PubMed ID: 18357405
[TBL] [Abstract][Full Text] [Related]
18. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
Raju J; Bird RP
Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis.
Hashem RM; Mahmoud MF; El-Moselhy MA; Soliman HM
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):995-1001. PubMed ID: 18787467
[TBL] [Abstract][Full Text] [Related]
20. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
